Skip to main content

Advertisement

SpringerLink
Log in

Using ICD9/10 codes for identifying ADPKD patients, a validation study

  • Research Letter
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Willey CJ, Blais JD, Hall AK, Krasa HB, Makin AJ, Czerwiec FS (2017) Prevalence of autosomal dominant polycystic kidney disease in the European Union. Nephrol Dial Transplant 32(8):1356–1363

    PubMed  Google Scholar 

  2. Kalot MA, El Alayli A, Al Khatib M, Husainat N, McGreal K, Jalal DI et al (2021) A computable phenotype for autosomal dominant polycystic kidney disease. Kidney 360 2(11):1728–1733

    Article  PubMed  PubMed Central  Google Scholar 

  3. Shivade C, Raghavan P, Fosler-Lussier E, Embi PJ, Elhadad N, Johnson SB et al (2014) A review of approaches to identifying patient phenotype cohorts using electronic health records. J Am Med Inform Assoc 21(2):221–230

    Article  PubMed  Google Scholar 

  4. Soroka S, Alam A, Bevilacqua M, Girard LP, Komenda P, Loertscher R et al (2018) Updated Canadian expert consensus on assessing risk of disease progression and pharmacological management of autosomal dominant polycystic kidney disease. Can J Kidney Health Dis 5:2054358118801589

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ahmad FS, Ricket IM, Hammill BG, Eskenazi L, Robertson HR, Curtis LH et al (2020) Computable phenotype implementation for a National, Multicenter Pragmatic Clinical Trial. Circ: Cardiovasc Qual Outcomes 13(6):e006292

    PubMed  Google Scholar 

  6. Bennett TD, DeWitt PE, Dixon RR, Kartchner C, Sierra Y, Ladell D et al (2017) Development and prospective validation of tools to accurately identify neurosurgical and critical care events in children with traumatic brain injury*. Pediatric Crit Care Med. 18(5):442–451

    Article  Google Scholar 

  7. Thomas RM, Koh I, Wilkinson K, Roetker N, Smith NL, Repp AB et al (2020) Development of a computable phenotype for hospital-acquired venous thrombosis: the medical inpatient thrombosis and hemostasis (MITH) study. Blood 136(Supplement 1):40–41

    Article  Google Scholar 

  8. Cohen SS, Roger VL, Weston SA, Jiang R, Movva N, Yusuf AA et al (2020) Evaluation of claims-based computable phenotypes to identify heart failure patients with preserved ejection fraction. Pharmacol Res Perspect 8(6):e00676

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Khera R, Mortazavi BJ, Sangha V, Warner F, Patrick Young H, Ross JS et al (2022) A multicenter evaluation of computable phenotyping approaches for SARS-CoV-2 infection and COVID-19 hospitalizations. NPJ Digit Med 5(1):27

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank Drs. Diana Jalal1,2, Alan S.L.Yu3, Vinamratha Rao3, and Abrar Alshorman3 for their editorial assistance in reviewing the manuscript. 1 Division of Nephrology and Hypertension, Department of Internal Medicine, University of Iowa, Iowa City, IA, USA. 2 Iowa City VA Medical Center, Iowa City, IA, USA. 3 Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.

Author information

Authors and Affiliations

  1. Division of Nephrology and Hypertension, Department of Internal Medicine, University of Iowa, Iowa City, IA, USA

    Shahed Ammar, Kathleen Borghoff & Lama Noureddine

  2. Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA

    Reem A. Mustafa

  3. Outcomes and Implementation Research Unit, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA

    Ibrahim K. El Mikati

  4. Division of Nephrology and Hypertension, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA

    Kathleen Borghoff

  5. Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada

    Reem A. Mustafa

  6. University of Iowa Carver College of Medicine, Campus Box C44-K, 200 Hawkins Dr., Iowa City, IA, 52242, USA

    Shahed Ammar

Authors
  1. Shahed Ammar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kathleen Borghoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ibrahim K. El Mikati
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Reem A. Mustafa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lama Noureddine
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shahed Ammar.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical approval

This article doesn’t include studies with human participants or animals performed by any of the authors.

Informed consent

This was a retrospective chart review for patients at UIHC and no consent was obtained.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ammar, S., Borghoff, K., El Mikati, I.K. et al. Using ICD9/10 codes for identifying ADPKD patients, a validation study. J Nephrol 37, 523–525 (2024). https://doi.org/10.1007/s40620-023-01780-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-023-01780-z

Search

Navigation